Just diagnosed with Drug-induced localized lipodystrophy?
You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Drug-induced localized lipodystrophy, look for clinical trials, and connect with others living with it — all in one place.
Open the full interactive Drug-induced localized lipodystrophy hub →Overview
Drug-induced localized lipodystrophy is a rare condition. Also known as Lipoatrophy caused by injected drug. Tomeko brings together the specialists, research, clinical trials, treatments and community for Drug-induced localized lipodystrophy so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.
Identifiers: ORPHA:90157 · ICD-10 E88.1 · GARD 0019126
Find care for Drug-induced localized lipodystrophy
Authoritative references for Drug-induced localized lipodystrophy
Research & market landscape for Drug-induced localized lipodystrophy
Following Drug-induced localized lipodystrophy for research or industry? Tomeko brings together the recruiting trials, the latest literature, patient organizations, and the specialist and care-center footprint for Drug-induced localized lipodystrophy — the real-world landscape behind the condition, in one place.
- Latest Drug-induced localized lipodystrophy research on PubMed ↗
- Recruiting Drug-induced localized lipodystrophy trials on ClinicalTrials.gov ↗
- Explore the Drug-induced localized lipodystrophy research & specialist footprint on Tomeko
Researchers, patient organizations & industry: Tomeko provides de-identified, no-PHI demand and engagement signal, trial awareness, and a labeled, editorially-firewalled presence for Drug-induced localized lipodystrophy and every rare condition. See how Tomeko works with industry →
Common questions
What is Drug-induced localized lipodystrophy?
Drug-induced localized lipodystrophy is a rare condition. Also known as Lipoatrophy caused by injected drug. For an authoritative medical description see the reference sources on this page; Tomeko brings the specialists, clinical trials, patient organizations and community for Drug-induced localized lipodystrophy together in one place.
What are the symptoms of Drug-induced localized lipodystrophy?
Symptoms of Drug-induced localized lipodystrophy vary from person to person. For a reviewed, plain-language overview see the authoritative references below (NIH GARD, Orphanet), and discuss your own symptoms with a clinician who treats Drug-induced localized lipodystrophy.
How is Drug-induced localized lipodystrophy treated?
Treatment for Drug-induced localized lipodystrophy depends on the individual and is managed by specialists. Use Tomeko to find clinicians and Centers of Excellence who see Drug-induced localized lipodystrophy, and review current options with them.
What causes Drug-induced localized lipodystrophy — is it genetic?
The cause and inheritance of Drug-induced localized lipodystrophy are described in the authoritative references linked on this page. A genetics or specialist clinician who treats Drug-induced localized lipodystrophy can explain what it means for you and your family.
I was just diagnosed with Drug-induced localized lipodystrophy — what should I do first?
Start by learning the basics from an authoritative source, find a specialist or center that sees Drug-induced localized lipodystrophy, and connect with a patient organization. Tomeko brings these together on one hub.
Where can I find a specialist for Drug-induced localized lipodystrophy?
Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Drug-induced localized lipodystrophy, filtered to your area.
Are there clinical trials for Drug-induced localized lipodystrophy?
Tomeko shows live, recruiting studies for Drug-induced localized lipodystrophy from ClinicalTrials.gov on the hub.
Related conditions
Other conditions on Tomeko you may be looking for:
- 2-aminoadipic 2-oxoadipic aciduria
- 3 beta-Hydroxysteroid dehydrogenase deficiency
- 3-hydroxy-3-methylglutaryl-CoA synthase deficiency
- 3-Hydroxyisobutyric aciduria
- 3-hydroxyisobutyryl-CoA hydrolase deficiency
- 3-methylglutaconic aciduria type 1
- 3-Methylglutaconic aciduria type 2
- 3-Methylglutaconic aciduria type 3
